Partners News BIOTRIP vision for biotech incubator
9 November 2021

BIOTRIP, the independent biotech incubator from TU Eindhoven and Radboudumc, presents the vision for its biotech incubator in its first animation. BIOTRIP will officially launch on January 1st, 2022.


 

For more on BIOTRIP, read more on how Radboudumc and Eindhoven University of Technology come together in BIOTRIP (in Dutch).

Related news items


T-Guard can reset immune system

1 December 2021

For 20 years, the Nijmegen based Radboudumc spin-off company Xenikos has been working on a drug that can reset the immune system. This reset will save lives of seriously ill patients. Now, after years of hard work, the moment of truth has arrived for T-guard.

read more

Sonlicromanol seems promising for certain cancers Khondrion announces publication in PLOS ONE of new research

13 July 2021

Khondrion announces publication in PLOS ONE of new research showing normalisation of prostate cancer stem cell mPGES-1 overexpression and inhibition of cancer spheroid growth by sonlicromanol’s active metabolite.

read more

Teaming up to develop an effective cure for mycobacterium abscessus disease using inhaled tigecycline

7 July 2021

PureIMS, Radboudumc, and Sever Pharma Solutions are now teaming up to develop an effective cure for this chronic and debilitating disease.

read more

Radboudumc and Eindhoven University of Technology join forces in BIOTRIP Biotech incubator to deliver the vaccines and immunotherapies of the future.

1 July 2021

BIOTRIP is a unique platform aimed at developing, commercializing, and making available of vaccins and immunotherapies.

read more

Radboud university medical center and Astherna join forces for new therapy for Stargardt disease

17 June 2021

RNA therapy for patients with a severe inherited retinal disease

read more